Travere Therapeutics (TVTX) Notes Payables (2011 - 2017)
Travere Therapeutics (TVTX) posted Notes Payables of $15.7 million for Q4 2017, down 22.0% on a QoQ basis from $20.1 million in Q3 2017, and down 29.99% year-over-year from $22.4 million in Q4 2016.
Travere Therapeutics (TVTX) Notes Payables (2011 - 2017) Analysis & Trends
Travere Therapeutics' Notes Payables history runs 7 years deep, the most recent figure standing at $15.7 million for Q4 2017.
- Quarterly Notes Payables fell 29.99% year-over-year to $15.7 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $15.7 million (down 29.99% YoY) and the FY2017 annual result came in at $15.7 million, down 29.99% from the prior year.
- Notes Payables was $15.7 million for Q4 2017 at Travere Therapeutics, down from $20.1 million in the prior quarter.
- Across five years, Notes Payables topped out at $91.2 million in Q2 2015 and bottomed at $10000.0 in Q1 2013.
- A 5-year average of $29.2 million and a median of $24.5 million in 2016 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2014 — Notes Payables surged 184700.0% — and 2016, when it slumped 63.42%.
- Travere Therapeutics' Notes Payables stood at $25.0 million in 2013, then advanced by 11.79% to $28.0 million in 2014, then surged by 38.66% to $38.8 million in 2015, then tumbled by 42.18% to $22.4 million in 2016, then declined by 29.99% to $15.7 million in 2017.
- Business Quant data shows TVTX's Notes Payables at $15.7 million in Q4 2017, $20.1 million in Q3 2017, and $22.5 million in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 15.71 Mn |
| Sep 30, 2017 | 20.14 Mn |
| Jun 30, 2017 | 22.46 Mn |
| Mar 31, 2017 | 21.18 Mn |
| Dec 31, 2016 | 22.44 Mn |
| Sep 30, 2016 | 28.96 Mn |
| Jun 30, 2016 | 33.36 Mn |
| Mar 31, 2016 | 24.47 Mn |
| Dec 31, 2015 | 38.81 Mn |
| Sep 30, 2015 | 42.12 Mn |
| Jun 30, 2015 | 91.20 Mn |
| Mar 31, 2015 | 63.39 Mn |
| Dec 31, 2014 | 27.99 Mn |
| Sep 30, 2014 | 18.48 Mn |
| Dec 31, 2013 | 25.04 Mn |
| Sep 30, 2013 | 10,000.00 |
| Mar 31, 2013 | 10,000.00 |
| Nov 30, 2012 | 9,572.00 |
| Feb 29, 2012 | 9,572.00 |
| Nov 30, 2011 | 25.00 Mn |